Campbell PJ - Search Results

1

Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing.

Campbell PJ, Pleasance ED, Stephens PJ, Dicks E, Rance R, Goodhead I, Follows GA, Green AR, Futreal PA, Stratton MR. Campbell PJ, et al. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13081-6. doi: 10.1073/pnas.0801523105. Epub 2008 Aug 22. Proc Natl Acad Sci U S A. 2008. PMID: 18723673 Free PMC article.

2

Management of the myeloproliferative disorders : distinguishing data from dogma.

Green AR, Vassiliou GS, Curtin N, Campbell PJ. Green AR, et al. Among authors: campbell pj. Hematol J. 2004;5 Suppl 3:S126-32. doi: 10.1038/sj.thj.6200438. Hematol J. 2004. PMID: 15190294 Review. No abstract available.

3

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, Wilkins BS, van der Walt JD, Reilly JT, Grigg AP, Revell P, Woodcock BE, Green AR; United Kingdom Medical Research Council Primary Thrombocythemia 1 Study. Harrison CN, et al. Among authors: campbell pj. N Engl J Med. 2005 Jul 7;353(1):33-45. doi: 10.1056/NEJMoa043800. N Engl J Med. 2005. PMID: 16000354 Free article. Clinical Trial.

4

The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders.

Scott LM, Campbell PJ, Baxter EJ, Todd T, Stephens P, Edkins S, Wooster R, Stratton MR, Futreal PA, Green AR. Scott LM, et al. Among authors: campbell pj. Blood. 2005 Oct 15;106(8):2920-1. doi: 10.1182/blood-2005-05-2087. Blood. 2005. PMID: 16204151 Free article. No abstract available.

5

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.

Campbell PJ, Griesshammer M, Döhner K, Döhner H, Kusec R, Hasselbalch HC, Larsen TS, Pallisgaard N, Giraudier S, Le Bousse-Kerdilès MC, Desterke C, Guerton B, Dupriez B, Bordessoule D, Fenaux P, Kiladjian JJ, Viallard JF, Brière J, Harrison CN, Green AR, Reilly JT. Campbell PJ, et al. Blood. 2006 Mar 1;107(5):2098-100. doi: 10.1182/blood-2005-08-3395. Epub 2005 Nov 17. Blood. 2006. PMID: 16293597 Free article.

6

Management of polycythemia vera and essential thrombocythemia.

Campbell PJ, Green AR. Campbell PJ, et al. Hematology Am Soc Hematol Educ Program. 2005:201-8. doi: 10.1182/asheducation-2005.1.201. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304381

7

The long-term outlook for essential thrombocythemia.

Campbell PJ, Green AR. Campbell PJ, et al. Mayo Clin Proc. 2006 Feb;81(2):157-8. doi: 10.4065/81.2.157. Mayo Clin Proc. 2006. PMID: 16471067 No abstract available.

8

Methods for the detection of the JAK2 V617F mutation in human myeloproliferative disorders.

Campbell PJ, Scott LM, Baxter EJ, Bench AJ, Green AR, Erber WN. Campbell PJ, et al. Methods Mol Med. 2006;125:253-64. doi: 10.1385/1-59745-017-0:253. Methods Mol Med. 2006. PMID: 16502590

9

Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia.

Scott LM, Scott MA, Campbell PJ, Green AR. Scott LM, et al. Among authors: campbell pj. Blood. 2006 Oct 1;108(7):2435-7. doi: 10.1182/blood-2006-04-018259. Epub 2006 Jun 13. Blood. 2006. PMID: 16772604 Free article.

10

Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia.

Fourouclas N, Campbell PJ, Bench AJ, Swanton S, Baxter EJ, Huntly BJ, Green AR. Fourouclas N, et al. Among authors: campbell pj. Haematologica. 2006 Jul;91(7):952-5. Haematologica. 2006. PMID: 16818283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page